These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. Edwards PD, Topping D, Kontaridis MI, Moldawer LL, Copeland EM, Lind DS. JPEN J Parenter Enteral Nutr; 1997 Mar; 21(4):215-9. PubMed ID: 9252947 [Abstract] [Full Text] [Related]
23. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Perretti M, Szabó C, Thiemermann C. Br J Pharmacol; 1995 Oct; 116(4):2251-7. PubMed ID: 8564256 [Abstract] [Full Text] [Related]
24. Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine. Kilbourn RG, Fonseca GA, Trissel LA, Griffith OW. Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S21-30. PubMed ID: 10685654 [Abstract] [Full Text] [Related]
25. Cytokines secreted by IL-2-activated lymphocytes induce endogenous nitric oxide synthesis and apoptosis in macrophages. Choi KS, Song EK, Yim CY. J Leukoc Biol; 2008 Jun; 83(6):1440-50. PubMed ID: 18339892 [Abstract] [Full Text] [Related]
26. Lymphocyte-mediated macrophage apoptosis during IL-12 stimulation. Yim JY, Yang SJ, Yim JM, Song MY, Rho HW, Yim SK, Han YH, Jeon SY, Kim HS, Yhim HY, Lee NR, Song EK, Kwak JY, Sohn MH, Yim CY. Cytokine; 2013 Oct; 64(1):62-70. PubMed ID: 23953854 [Abstract] [Full Text] [Related]
27. Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis. Gomaa A, Elshenawy M, Afifi N, Mohammed E, Thabit R. Int Immunopharmacol; 2010 Nov; 10(11):1406-14. PubMed ID: 20800711 [Abstract] [Full Text] [Related]
28. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Studer RK, Georgescu HI, Miller LA, Evans CH. Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918 [Abstract] [Full Text] [Related]
29. Nitric oxide: a cytokine-induced regulator of bone resorption. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N. J Bone Miner Res; 1995 Jul; 10(7):1040-9. PubMed ID: 7484279 [Abstract] [Full Text] [Related]
30. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS. J Exp Med; 1994 Feb 01; 179(2):651-60. PubMed ID: 7507509 [Abstract] [Full Text] [Related]
31. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. J Rheumatol; 1995 Oct 01; 22(10):1922-8. PubMed ID: 8991992 [Abstract] [Full Text] [Related]
32. Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats. Presle N, Cipolletta C, Jouzeau JY, Abid A, Netter P, Terlain B. Arthritis Rheum; 1999 Oct 01; 42(10):2094-102. PubMed ID: 10524680 [Abstract] [Full Text] [Related]
33. Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Wu G. Diabetes; 1995 Mar 01; 44(3):360-4. PubMed ID: 7533735 [Abstract] [Full Text] [Related]
34. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cifone MG, Festuccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A. Cell Immunol; 1994 Aug 01; 157(1):181-94. PubMed ID: 7518750 [Abstract] [Full Text] [Related]
35. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites. Thiesson HC, Skøtt O, Jespersen B, Schaffalitzky de Muckadell OB. Am J Gastroenterol; 2003 Jan 01; 98(1):180-6. PubMed ID: 12526955 [Abstract] [Full Text] [Related]
36. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster JR, McDaniel ML. Biochem J; 1992 Oct 01; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465 [Abstract] [Full Text] [Related]
37. Inhibition of nitric oxide synthesis in wounds: pharmacology and effect on accumulation of collagen in wounds in mice. Schäffer MR, Tantry U, Thornton FJ, Barbul A. Eur J Surg; 1999 Mar 01; 165(3):262-7. PubMed ID: 10231662 [Abstract] [Full Text] [Related]
38. Augmentation of antitumor effect on syngeneic murine solid tumors by an interleukin 2 slow delivery system, the IL-2 mini-pellet. Fujiwara T, Sakagami K, Matsuoka J, Shiozaki S, Fujioka K, Takada Y, Uchida S, Onoda T, Orita K. Biotherapy; 1991 Mar 01; 3(3):203-9. PubMed ID: 1854589 [Abstract] [Full Text] [Related]
39. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK, Rivier C. J Neuroendocrinol; 1998 May 01; 10(5):353-62. PubMed ID: 9663649 [Abstract] [Full Text] [Related]